Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Sanofi ADR (SNYN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
802.00 +0.00    +0.00%
- Delayed Data. Currency in MXN ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 802.00 - 802.00
Type:  Equity
Market:  Mexico
ISIN:  US80105N1054 
S/N:  80105N105
Sanofi ADR 802.00 +0.00 +0.00%

SNYN Share Price Overview

 
Assess today's live Sanofi ADR (SNY) share price, performance and insights using our live NASDAQ: SNY stock exchange data.

Analyse the historical data and Sanofi ADR share price performance charts on this page. Our technical summary section provides analysis on Sanofi ADR share price buy/sell indicators using real-time data (or discuss the Sanofi ADR (SNY) stock price today with other investors in the Sanofi ADR NASDAQ share price and sentiment chat forum).

Use the dropdown to select a relevant stock exchange for the current NASDAQ SNY share price (ISIN: US80105N1054) to enhance your trading decisions with our free investment tools and resources.

What Is the Sanofi ADR Share Price Today?
The Sanofi ADR share price today is 802.00.

What Is the Stock Symbol for Sanofi ADR
The stock symbol (or 'ticker') for Sanofi ADR is "SNY."

What Stock Exchange Does Sanofi ADR Trade On?
Sanofi ADR is listed and trades on the NASDAQ stock exchange.

Is Sanofi ADR a Good Stock to Buy?
Determining whether Sanofi ADR—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close795
Day's Range802 - 802
Revenue46.03B
Open802
52 wk Range718.84 - 1,033.06
EPS4.31
VolumeN/A
Market Cap2.03T
Dividend (Yield)1.478 (3.16%)
Average Volume (3m)957
P/E Ratio12.27
Beta0.444
1-Year Change - 21.08%
Shares Outstanding1,248,557,653
Next Earnings DateApr 25, 2024
What is your sentiment on Sanofi ADR?
or
Vote to see community's results!

Sanofi ADR News Today


Sanofi to overhaul US operations of vaccines, cut jobs
Sanofi to overhaul US operations of vaccines, cut jobs By Reuters - Apr 18, 2024

(Reuters) - French drugmaker Sanofi (EPA:SASY) said on Thursday it would restructure the U.S. com­mer­cial op­er­a­tions for its vac­cines and cut an undis­closed num­ber of jobs....

Technical Summary

Type 5 Min 15 Min Hourly Daily Monthly
Moving Averages Strong Sell Sell Sell Strong Sell Sell
Technical Indicators Neutral BUY Sell Sell Strong Sell
Summary Sell Neutral Sell Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Tri-Star Bullish 5H Current
Tri-Star Bullish 1D Current
Completed Patterns
Tri-Star Bullish 1H 3 Apr 02, 2024 18:00
Tri-Star Bullish 30 4 Apr 02, 2024 18:00
Bullish doji Star 1D 5 Mar 04, 2024

Sanofi ADR Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 47.88 0.00 0.00 916,999 +1.55% USD  
  BATS Europe 88.75 0.00 0.00 225 +0.77% EUR  
  London 88.77 87.12 89.89 1,256,675 +0.82% EUR  
  Mexico 802.00 0.00 0.00 0 +0.00% MXN  
  Milan 88.23 0.00 0.00 467 +0.01% EUR  
  Xetra 88.910 88.850 89.890 2,751 +0.91% EUR  
  Frankfurt 88.82 89.13 89.57 503 +0.48% EUR  
  TradeGate 89.48 89.14 89.48 3,659 +1.53% EUR  
  Paris 88.85 0.00 0.00 1,062,952 +0.77% EUR 16:35:10  
  Vienna 86.80 86.65 86.78 0 +0.00% EUR  

Trending Stocks

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  IAG 175.95 179.35 175.95 +0.75 +0.43% 21.47M 16:35:59  
  Rolls-Royce Holdings 417.20 417.20 406.60 +10.90 +2.68% 62.87M 16:35:59  
  Barclays 192.24 193.58 190.48 +3.06 +1.62% 76.49M 16:35:59  
  Lloyds Banking 51.34 51.69 50.88 +0.20 +0.39% 190.29M 16:35:59  
  Vodafone Group PLC 69.620 70.640 69.620 0.000 0.00% 90.52M 16:35:59  
  HSBC 667.70 669.60 663.80 +1.20 +0.18% 28.45M 16:35:59  
  BP 523.10 530.60 521.00 +0.60 +0.12% 51.68M 16:35:59  
  Reliance Industries Ltd 70.50 71.10 70.30 -1.60 -2.22% 80.20K 16:35:59  
  Legal & General 253.10 255.00 251.20 +2.70 +1.08% 16.70M 16:35:59  
  British American Tobacco 2,360.0 2,389.0 2,360.0 0.0 0.00% 6.43M 16:35:59  

%SHORT_NAME% Company Profile

IndustryPharmaceuticals
SectorHealthcare
Employees

86088

Equity Type

DRC

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SNY Price Commentary

Write your thoughts about Sanofi
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email